These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8877676)
21. Comparative bioavailability of a premixed, ready-to-use formulation of intravenous amiodarone with traditional admixture in healthy subjects. Cushing DJ; Adams MP; Cooper WD; Agha B; Souney PF J Clin Pharmacol; 2012 Feb; 52(2):214-21. PubMed ID: 21257800 [TBL] [Abstract][Full Text] [Related]
22. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration. Kotake T; Takada M; Goto T; Komamura K; Kamakura S; Morishita H J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989 [TBL] [Abstract][Full Text] [Related]
23. Time course of myocardial amiodarone uptake in the piglet heart using a chronic animal model. Beder SD; Cohen MH; BenShachar G Pediatr Cardiol; 1998; 19(3):204-11. PubMed ID: 9568214 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic monitoring of amiodarone: pharmacokinetics and evaluation of the relationship between effect and dose/concentration. Hrudikova Vyskocilova E; Grundmann M; Duricova J; Kacirova I Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):134-143. PubMed ID: 28414390 [TBL] [Abstract][Full Text] [Related]
25. Interaction between amiodarone and lidocaine. Ha HR; Candinas R; Stieger B; Meyer UA; Follath F J Cardiovasc Pharmacol; 1996 Oct; 28(4):533-9. PubMed ID: 8891878 [TBL] [Abstract][Full Text] [Related]
29. Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure. Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Ghadanfar M; Friedrich T; Pouleur H Am J Cardiol; 2001 Jun; 87(11):1250-4. PubMed ID: 11377349 [TBL] [Abstract][Full Text] [Related]
30. Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706 [TBL] [Abstract][Full Text] [Related]
31. Influence of CYP3A metabolizer status on the pharmacokinetics and pharmacodynamics of amiodarone. Micuda S; Hodac M; Parízek P; Pleskot M; Sispera L; Cerman J; Maláková J; Martínková J; Pidrman V Acta Medica (Hradec Kralove); 2000; 43(3):95-101. PubMed ID: 11089277 [TBL] [Abstract][Full Text] [Related]
32. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor. Teng R; Sarich TC; Eriksson UG; Hamer JE; Gillette S; Schützer KM; Carlson GF; Kowey PR J Clin Pharmacol; 2004 Sep; 44(9):1063-71. PubMed ID: 15317834 [TBL] [Abstract][Full Text] [Related]
33. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. Zhou L; Chen BP; Kluger J; Fan C; Chow MS J Am Coll Cardiol; 1998 Jun; 31(7):1672-8. PubMed ID: 9626850 [TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients. Araki R; Yukawa E; Nakashima MN; Fukuchi H; Sasaki H; Yano K; Nakashima M Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593 [TBL] [Abstract][Full Text] [Related]
35. Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Meng X; Mojaverian P; Doedée M; Lin E; Weinryb I; Chiang ST; Kowey PR Am J Cardiol; 2001 Feb; 87(4):432-5. PubMed ID: 11179527 [TBL] [Abstract][Full Text] [Related]
36. Correlation of amiodarone dosage, heart rate, QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations. Pollak PT; Sharma AD; Carruthers SG Am J Cardiol; 1989 Nov; 64(18):1138-43. PubMed ID: 2816765 [TBL] [Abstract][Full Text] [Related]
37. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms. Shayeganpour A; El-Kadi AO; Brocks DR Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463 [TBL] [Abstract][Full Text] [Related]
38. Effect of phenytoin on the clinical pharmacokinetics of amiodarone. Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084 [TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Remme WJ; Kruyssen HA; Look MP; van Hoogenhuyze DC; Krauss XH Am Heart J; 1991 Jul; 122(1 Pt 1):96-103. PubMed ID: 2063768 [TBL] [Abstract][Full Text] [Related]
40. The role of intravenous amiodarone in the management of cardiac arrhythmias. Desai AD; Chun S; Sung RJ Ann Intern Med; 1997 Aug; 127(4):294-303. PubMed ID: 9265430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]